$BLUE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in bluebird bio, Inc.. Get notifications about new insider transactions in bluebird bio, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 13 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 113.59 | 6,000 | 681,538 | 24,905 | 30.9 K to 24.9 K (-19.41 %) |
| Dec 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 6,000 | 33,002 | 30,905 | 24.9 K to 30.9 K (+24.09 %) |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 31,300 | |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 14,600 | |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 138.27 | 252 | 34,845 | 30,871 | 31.1 K to 30.9 K (-0.81 %) |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 137.70 | 948 | 130,538 | 31,123 | 32.1 K to 31.1 K (-2.96 %) |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 136.49 | 600 | 81,894 | 32,071 | 32.7 K to 32.1 K (-1.84 %) |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 32,671 | 32 K to 32.7 K (+2.19 %) |
| Nov 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 31,971 | 31.4 K to 32 K (+1.91 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 5,000 | 27,502 | 26,951 | |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 135.10 | 1,700 | 229,662 | 24,905 | 26.6 K to 24.9 K (-6.39 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 134.12 | 1,702 | 228,264 | 26,605 | 28.3 K to 26.6 K (-6.01 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 133.08 | 600 | 79,850 | 28,307 | 28.9 K to 28.3 K (-2.08 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 131.37 | 501 | 65,818 | 28,907 | 29.4 K to 28.9 K (-1.70 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 130.42 | 405 | 52,819 | 29,408 | 29.8 K to 29.4 K (-1.36 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 128.30 | 92 | 11,804 | 29,813 | 29.9 K to 29.8 K (-0.31 %) |
| Nov 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 5,000 | 27,502 | 29,905 | 24.9 K to 29.9 K (+20.08 %) |
| Oct 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 1,500 | 36,705 | 22,021 | |
| Oct 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 136.83 | 100 | 13,683 | 35,495 | 35.6 K to 35.5 K (-0.28 %) |
| Oct 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 135.70 | 300 | 40,709 | 35,595 | 35.9 K to 35.6 K (-0.84 %) |
| Oct 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 134.95 | 1,100 | 148,447 | 35,895 | 37 K to 35.9 K (-2.97 %) |
| Oct 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 1,500 | 36,705 | 36,995 | 35.5 K to 37 K (+4.23 %) |
| Oct 10 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 32,000 | |
| Oct 10 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 15,200 | |
| Oct 10 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 140.75 | 1,410 | 198,458 | 31,371 | 32.8 K to 31.4 K (-4.30 %) |
| Oct 10 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 139.85 | 390 | 54,543 | 32,781 | 33.2 K to 32.8 K (-1.18 %) |
| Oct 10 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 33,171 | 32.5 K to 33.2 K (+2.16 %) |
| Oct 10 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 32,471 | 31.9 K to 32.5 K (+1.88 %) |
| Oct 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 5,000 | 27,502 | 31,951 | |
| Oct 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 139.95 | 448 | 62,699 | 24,905 | 25.4 K to 24.9 K (-1.77 %) |
| Oct 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 139.26 | 4,552 | 633,889 | 25,353 | 29.9 K to 25.4 K (-15.22 %) |
| Oct 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 5,000 | 27,502 | 29,905 | 24.9 K to 29.9 K (+20.08 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 1,500 | 36,705 | 23,521 | |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 151.57 | 299 | 45,318 | 35,495 | 35.8 K to 35.5 K (-0.84 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 150.24 | 700 | 105,165 | 35,495 | 36.2 K to 35.5 K (-1.93 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 149.22 | 501 | 74,760 | 36,494 | 37 K to 36.5 K (-1.35 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 1,500 | 36,705 | 36,995 | 35.5 K to 37 K (+4.23 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 152.00 | 67 | 10,184 | 1,000 | 1.1 K to 1,000 (-6.28 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 151.22 | 501 | 75,762 | 1,067 | 1.6 K to 1.1 K (-31.95 %) |
| Sep 12 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 150.06 | 432 | 64,825 | 1,568 | 2 K to 1.6 K (-21.60 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 32,700 | |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 15,800 | |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 166.25 | 100 | 16,625 | 31,871 | 32 K to 31.9 K (-0.31 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 165.28 | 200 | 33,055 | 31,971 | 32.2 K to 32 K (-0.62 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 164.03 | 213 | 34,939 | 32,171 | 32.4 K to 32.2 K (-0.66 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 162.90 | 510 | 83,081 | 32,384 | 32.9 K to 32.4 K (-1.55 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 161.83 | 777 | 125,742 | 32,894 | 33.7 K to 32.9 K (-2.31 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 33,671 | 33 K to 33.7 K (+2.12 %) |
| Sep 07 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 32,971 | 32.4 K to 33 K (+1.85 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 7,000 | 38,503 | 36,951 | |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 168.25 | 1,425 | 239,751 | 24,905 | 26.3 K to 24.9 K (-5.41 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 167.30 | 1,070 | 179,010 | 26,330 | 27.4 K to 26.3 K (-3.91 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 166.50 | 2,083 | 346,821 | 27,400 | 29.5 K to 27.4 K (-7.07 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 165.53 | 2,422 | 400,911 | 29,483 | 31.9 K to 29.5 K (-7.59 %) |
| Sep 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 7,000 | 38,503 | 31,905 | 24.9 K to 31.9 K (+28.11 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 7,250 | 177,408 | 25,021 | |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 4,007 | 22,040 | 0 | |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 8,743 | 18,241 | 0 | |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 176.03 | 978 | 172,155 | 35,495 | 36.5 K to 35.5 K (-2.68 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 175.37 | 19,022 | 3,335,793 | 36,473 | 55.5 K to 36.5 K (-34.28 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 7,250 | 177,408 | 55,495 | 48.2 K to 55.5 K (+15.03 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 4,007 | 22,040 | 48,245 | 44.2 K to 48.2 K (+9.06 %) |
| Sep 04 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 8,743 | 18,241 | 44,238 | 35.5 K to 44.2 K (+24.63 %) |
| Aug 22 2018 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 158.10 | 100 | 15,810 | 15,667 | 15.8 K to 15.7 K (-0.63 %) |
| Aug 22 2018 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 158.05 | 159 | 25,130 | 15,767 | 15.9 K to 15.8 K (-1.00 %) |
| Aug 14 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 1,500 | 8,251 | 4,007 | |
| Aug 14 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 158.57 | 105 | 16,650 | 35,495 | 35.6 K to 35.5 K (-0.29 %) |
| Aug 14 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 157.86 | 620 | 97,872 | 35,600 | 36.2 K to 35.6 K (-1.71 %) |
| Aug 14 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 156.63 | 350 | 54,820 | 36,220 | 36.6 K to 36.2 K (-0.96 %) |
| Aug 14 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 155.41 | 425 | 66,048 | 36,570 | 37 K to 36.6 K (-1.15 %) |
| Aug 14 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 1,500 | 8,251 | 36,995 | 35.5 K to 37 K (+4.23 %) |
| Aug 10 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 22.53 | 4,438 | 99,988 | 2,248 | |
| Aug 10 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 22.53 | 4,438 | 99,988 | 21,610 | 17.2 K to 21.6 K (+25.84 %) |
| Aug 08 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 33,400 | |
| Aug 08 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 16,400 | |
| Aug 08 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 157.30 | 210 | 33,033 | 32,371 | 32.6 K to 32.4 K (-0.64 %) |
| Aug 08 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 156.51 | 1,590 | 248,856 | 32,581 | 34.2 K to 32.6 K (-4.65 %) |
| Aug 08 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 34,171 | 33.5 K to 34.2 K (+2.09 %) |
| Aug 08 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 33,471 | 32.9 K to 33.5 K (+1.83 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 21,500 | 118,259 | 5,507 | |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 155.42 | 500 | 77,710 | 35,495 | 36 K to 35.5 K (-1.39 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 154.58 | 3,100 | 479,195 | 35,995 | 39.1 K to 36 K (-7.93 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 153.35 | 3,358 | 514,940 | 39,095 | 42.5 K to 39.1 K (-7.91 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 152.51 | 2,601 | 396,687 | 42,453 | 45.1 K to 42.5 K (-5.77 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 151.59 | 3,976 | 602,712 | 45,054 | 49 K to 45.1 K (-8.11 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 150.31 | 7,965 | 1,197,249 | 49,030 | 57 K to 49 K (-13.97 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 21,500 | 118,259 | 56,995 | 35.5 K to 57 K (+60.57 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 7,000 | 38,503 | 43,951 | |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 152.10 | 100 | 15,210 | 24,905 | 25 K to 24.9 K (-0.40 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 151.22 | 1,110 | 167,849 | 25,005 | 26.1 K to 25 K (-4.25 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 150.18 | 5,790 | 869,527 | 26,115 | 31.9 K to 26.1 K (-18.15 %) |
| Aug 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 7,000 | 38,503 | 31,905 | 24.9 K to 31.9 K (+28.11 %) |
| Jul 13 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 3,000 | 16,501 | 50,951 | |
| Jul 13 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 180.15 | 3,000 | 540,443 | 24,905 | 27.9 K to 24.9 K (-10.75 %) |
| Jul 13 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 3,000 | 16,501 | 27,905 | 24.9 K to 27.9 K (+12.05 %) |
| Jul 11 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 172.67 | 326 | 56,289 | 17,172 | 17.5 K to 17.2 K (-1.86 %) |
| Jul 11 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 171.60 | 940 | 161,306 | 17,498 | 18.4 K to 17.5 K (-5.10 %) |
| Jul 11 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 170.68 | 970 | 165,556 | 18,438 | 19.4 K to 18.4 K (-5.00 %) |
| Jul 11 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 169.64 | 2,290 | 388,484 | 19,408 | 21.7 K to 19.4 K (-10.55 %) |
| Jul 11 2018 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 168.47 | 600 | 101,080 | 21,698 | 22.3 K to 21.7 K (-2.69 %) |
| Jul 03 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 10,000 | 55,004 | 53,951 | |
| Jul 03 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 154.85 | 1,200 | 185,816 | 24,905 | 26.1 K to 24.9 K (-4.60 %) |
| Jul 03 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 154.07 | 5,982 | 921,630 | 26,105 | 32.1 K to 26.1 K (-18.64 %) |
| Jul 03 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 153.36 | 2,818 | 432,158 | 32,087 | 34.9 K to 32.1 K (-8.07 %) |
| Jul 03 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 10,000 | 55,004 | 34,905 | 24.9 K to 34.9 K (+40.15 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Grant | A | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Grant | A | 0.00 | 1,000 | 0 | 4,176 | 3.2 K to 4.2 K (+31.49 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Director | Grant | A | 0.00 | 1,000 | 0 | 3,700 | 2.7 K to 3.7 K (+37.04 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Mandell James | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | A | 183.10 | 5,600 | 1,025,360 | 5,600 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Grant | A | 0.00 | 1,400 | 0 | 4,200 | 2.8 K to 4.2 K (+50.00 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Grant | A | 0.00 | 1,000 | 0 | 3,700 | 2.7 K to 3.7 K (+37.04 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Director | Grant | A | 0.00 | 1,000 | 0 | 3,000 | 2 K to 3 K (+50.00 %) |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Agwunobi John O | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
| Jun 22 2018 | BLUE | bluebird bio, Inc. | Agwunobi John O | Director | Grant | A | 0.00 | 1,000 | 0 | 3,700 | 2.7 K to 3.7 K (+37.04 %) |
| Jun 20 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 181.36 | 1,800 | 326,450 | 25,371 | 27.2 K to 25.4 K (-6.62 %) |
| Jun 20 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 177.30 | 300 | 53,190 | 27,171 | 27.5 K to 27.2 K (-1.09 %) |
| Jun 20 2018 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 175.65 | 1,801 | 316,338 | 27,471 | 29.3 K to 27.5 K (-6.15 %) |
| Jun 18 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 190.38 | 300 | 57,115 | 0 | 300 to 0 (-100.00 %) |
| Jun 18 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 189.83 | 700 | 132,878 | 300 | 1,000 to 300 (-70.00 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | M | 47.87 | 4,000 | 191,480 | 0 | |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | M | 30.47 | 2,000 | 60,940 | 0 | |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 191.72 | 500 | 95,860 | 1,000 | 1.5 K to 1,000 (-33.33 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 190.93 | 700 | 133,652 | 1,500 | 2.2 K to 1.5 K (-31.82 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 190.15 | 1,000 | 190,145 | 2,200 | 3.2 K to 2.2 K (-31.25 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 188.48 | 300 | 56,543 | 3,200 | 3.5 K to 3.2 K (-8.57 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 187.28 | 500 | 93,640 | 3,500 | 4 K to 3.5 K (-12.50 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 186.49 | 3,000 | 559,461 | 4,000 | 7 K to 4 K (-42.86 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Buy | M | 47.87 | 4,000 | 191,480 | 7,000 | 3 K to 7 K (+133.33 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Buy | M | 30.47 | 2,000 | 60,940 | 3,000 | 1,000 to 3 K (+200.00 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 24.47 | 13,000 | 318,110 | 14,000 | |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 191.73 | 1,000 | 191,725 | 24,905 | 25.9 K to 24.9 K (-3.86 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 190.96 | 1,600 | 305,537 | 25,905 | 27.5 K to 25.9 K (-5.82 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 190.06 | 1,300 | 247,083 | 27,505 | 28.8 K to 27.5 K (-4.51 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 188.44 | 600 | 113,063 | 28,805 | 29.4 K to 28.8 K (-2.04 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 186.81 | 2,800 | 523,072 | 29,405 | 32.2 K to 29.4 K (-8.69 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 186.23 | 5,700 | 1,061,485 | 32,205 | 37.9 K to 32.2 K (-15.04 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 24.47 | 13,000 | 318,110 | 37,905 | 24.9 K to 37.9 K (+52.20 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Option Exercise | M | 68.65 | 3,500 | 240,275 | 40,662 | |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 199.11 | 3,500 | 696,892 | 17,500 | 21 K to 17.5 K (-16.67 %) |
| Jun 06 2018 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Buy | M | 68.65 | 3,500 | 240,275 | 21,000 | 17.5 K to 21 K (+20.00 %) |
| May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 24.47 | 13,000 | 318,110 | 27,000 | |
| May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 180.04 | 3,000 | 540,107 | 24,905 | 27.9 K to 24.9 K (-10.75 %) |
| May 04 2018 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 179.56 | 698 | 125,336 | 27,905 | 28.6 K to 27.9 K (-2.44 %) |